DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Fevipiprant
Fevipiprant
Japanese Guidelines for Adult Asthma 2020*
Improved Homology Modeling of the Human & Rat EP4 Prostanoid Receptors
Q4 2019/20 Initiation
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
Investigational Allergology and Clinical Immunology
PDCO Minutes of the 20-23 February 2018 Meeting
Structures of the Human PGD2 Receptor CRTH2 Reveal Novel Mechanisms for Ligand Recognition
(CRTH2) Antagonists in Asthma: a Systematic Review and Meta-Analysis Protocol AUTHORS Liu, Wei; Min, Jie; Jiang, Hongli; Mao, Bing
Fevipiprant (QAW039), a Slowly Dissociating Crth2 Antagonist with the Potential for Improved Clinical Efficacy S
Data on the Oral Crth2 Antagonist QAW039 (Fevipiprant) in Patients with Uncontrolled Allergic Asthma
Stembook 2018.Pdf
Risk Assessment of Reactive Metabolites in Drug Discovery: a Focus on Acyl Glucuronides and Acyl-Coa Thioesters
The Biology of Prostaglandins and Their Role As a Target for Allergic Airway Disease Therapy
Innovative Therapies for Severe Asthma
Product List
Fevipiprant, an Oral Prostaglandin DP2 Receptor (Crth2) Antagonist, in Allergic Asthma Uncontrolled on Low-Dose Inhaled Corticosteroids
Lääkeaineiden Yleisnimet (INN-Nimet) 31.12.2019
Ramatroban-Based Analogues Containing Fluorine Group As Potential 18F-Labeled Positron Emission Tomography (PET) G-Protein Coupled Receptor 44 (GPR44) Tracers
Top View
Towards Clinically Applicable Biomarkers for Asthma
Optumrx Brand Pipeline Forecast
Anti-COVID-19 Compound Library (96-Well)
QAW039 a Slowly Dissociating Crth2 Antagonist with the Potential For
Supplemental Data
Optumrx Brand Pipeline Forecast
Prostaglandin Receptor
Bioactive Compound Library Plus (96-Well)
Fevipiprant (QAW039), a Slowly Dissociating Crth2 Antagonist with the Potential for Improved Clinical Efficacy S
Prostaglandin-Cytokine Crosstalk in Chronic Inflammation
QAW039/Fevipiprant a 2-Treatment Period, Randomized, Placebo
Vol I Issue IV
Japanese Guidelines for Adult Asthma 2020 Allergology International
And Allergy: Chicken Or Egg; Which Comes First?
Study Protocol and Results
Spotlight on Fevipiprant and Its Potential in the Treatment of Asthma: Evidence to Date
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Biologics in Chronic Rhinosinusitis with Nasal Polyposis
January 2018 a View Into Upcoming Specialty and Traditional Drugs TABLE of CONTENTS
Drug Repurposing Compound Library (96-Well)
Endocrinology
April 2018 a View Into Upcoming Specialty and Traditional Drugs TABLE of CONTENTS
Download Product Insert (PDF)
Respiratory Research Review™
LUSTER-1 and -2: Two Randomized Controlled Trials of the Prostaglandin
Prostaglandin D2 Contributes to Cisplatin-Induced Neuropathic Pain in Rats Via DP2 Receptor in the Spinal Cord
Comparing Biologicals and Small Molecule Drug Therapies for Chronic Respiratory Diseases
Severe Asthma